Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients for Primary Prevention
Open Access
- 1 February 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Arrhythmia and Electrophysiology
- Vol. 5 (1), 147-154
- https://doi.org/10.1161/circep.111.968008
Abstract
Background—: An implantable cardioverter-defibrillator (ICD) is the therapy of choice for primary prevention in patients with ischemia who are at risk for sudden cardiac death (SCD). One third of patients with significant coronary disease have chronic total coronary occlusion (CTO), which is associated with long-term mortality in patients with previous myocardial infarction. However, the impact of CTO on the occurrence of ventricular arrhythmias and long-term mortality in ICD recipients remains unknown. Methods and Results—: All consecutive patients with coronary artery disease receiving ICD therapy for the prevention of SCD were included in the study. Among other characteristics, the existence of CTO was assessed. During follow-up, the occurrence of appropriate device delivery because of ventricular arrhythmias as well as mortality were noted. A total of 162 patients (mean age, 62±9 years; 93% men) with an ICD were included and followed for a median of 26 months (interquartile range, 12–42). At least 1 CTO was present in 71 (44%) patients. Appropriate device therapy was detected in 18% of the patients during the follow-up. The presence of CTO was associated with higher ventricular arrhythmia and mortality rates (log-rank test, P =0.003). Conclusions—: In patients with ischemic heart disease receiving ICDs for primary prevention of SCD, CTO is an independent predictor for the occurrence of ventricular arrhythmias and has an adverse impact on long-term mortality.Keywords
This publication has 30 references indexed in Scilit:
- Effectiveness of recanalization of chronic total occlusions: A systematic review and meta-analysisAmerican Heart Journal, 2010
- Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic CardiomyopathyPacing and Clinical Electrophysiology, 2010
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseThe New England Journal of Medicine, 2009
- Electrophysiological Effects of Late Percutaneous Coronary Intervention for Infarct-Related Coronary Artery OcclusionCirculation, 2009
- Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI)EP Europace, 2008
- Prophylactic Catheter Ablation for the Prevention of Defibrillator TherapyThe New England Journal of Medicine, 2007
- Determinants of Coronary Steal in Chronic Total Coronary Occlusions: Donor Artery, Collateral, and Microvascular ResistanceJournal of the American College of Cardiology, 2006
- Effect of Chronic Total Coronary Occlusion on Treatment StrategyThe American Journal of Cardiology, 2005
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionThe New England Journal of Medicine, 2002
- Effect of coronary angioplasty on late potentials one to two weeks after acute myocardial infarctionThe American Journal of Cardiology, 1992